Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07118592) titled 'Genetic Architecture of Natriuretic Peptides and Blood Pressure Response' on Aug. 5.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Crossover Assignment. Primary purpose: Prevention. Masking: Single (Outcomes Assessor).
Primary Sponsor: University of Alabama at Birmingham
Condition:
Hypertension (HTN)
Cardiometabolic Diseases
Intervention:
Dietary Supplement: Low Salt Diet
Dietary Supplement: High Salt Diet
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: January 1, 2026
Target Sample Size: 200
Countries of Recruitment:
United States
To ...